EUVIMEDEUVIMED entdecken
Crossref

The inhibitor of MyoD Family A (I-MFA) regulates megakaryocyte lineage commitment and terminal differentiation

Jeremy S Houser, Maulin Patel, Kyle Wright, Marta Onopiuk, Leonidas Tsiokas, Mary Beth Humphrey

Blood Cells, Molecules, and Diseases · 2023-09 · 102 · 102760

DOI: 10.1016/j.bcmd.2023.102760 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood Cells, Molecules, and Diseases, 2023-09. Verfasst von Jeremy S Houser und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States of America. Hauptthemen laut MEDLINE: Megakaryocytes, Bone Marrow. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: NIAMS NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hematopoiesis and lineage commitment are regulated by several conserved cell-intrinsic signaling pathways, including MAPKs and β-catenin/TCF/LEF. The Inhibitor of MyoD Family A (I-MFA), a transcriptional repressor and tumor suppressor gene, interacts with these pathways and is dysregulated in chronic and acute myeloid leukemias, suggesting it may play a role in development and differentiation during hematopoiesis. To study this, immune cell populations in the bone marrow (BM) and periphery were analyzed in mice lacking Mdfi, encoding I-MFA (I-MFA-/-), and wild type (WT) controls. I-MFA-/- mice had reduced spleen and BM cellularity, with significant hyposplenism, compared to WT mice. In blood, total red blood cells and platelet counts were significantly reduced in I-MFA-/- mice, accompanied by a reduction in megakaryocyte (MK)/erythrocyte progenitor cells and an increase in myeloid progenitors in BM compared to WT mice. The K562 cell line exhibits PMA-induced MK differentiation, and shRNA knockdown of I-MFA resulted in reduced differentiation compared to control, with an increase and prolongation in phospho-JNK and phospho-ERK signaling. Overexpression of I-MFA promoted MK differentiation. These results suggest I-MFA plays a cell-intrinsic role in the response to differentiation signals, an effect that can be explored in the context of hematological cancers or other blood proliferative disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MegakaryocytesBone MarrowMiceAnimalsCell DifferentiationHematopoiesisBone Marrow CellsCell Lineage

Stichwörter der Autor:innen

And anemiaGlobal I-MFA deletion in mice causes decreased terminal differentiation of HSCIncreased myeloid progenitorsThrombocytopenia

Autor:innen und Institutionen

  • Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States of America.
  • Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States of America.
  • Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States of America.
  • Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States of America; Oklahoma City Veteran's Affairs Medical Center, Oklahoma City, OK, United States of America. Electronic…

Förderung

  • NIAMS NIH HHS
  • NIAID NIH HHS

Zitieren

APA

Houser, J. S., Patel, M., Wright, K., Onopiuk, M., Tsiokas, L., & Humphrey, M. B. (2023). The inhibitor of MyoD Family A (I-MFA) regulates megakaryocyte lineage commitment and terminal differentiation. Blood Cells, Molecules, and Diseases, 102, 102760. https://doi.org/10.1016/j.bcmd.2023.102760

Vancouver

Houser JS, Patel M, Wright K, Onopiuk M, Tsiokas L, Humphrey MB. The inhibitor of MyoD Family A (I-MFA) regulates megakaryocyte lineage commitment and terminal differentiation. Blood Cells, Molecules, and Diseases. 2023;102:102760. doi:10.1016/j.bcmd.2023.102760

BibTeX
@article{Houser2023,
  author = {Houser, Jeremy S and Patel, Maulin and Wright, Kyle and Onopiuk, Marta and Tsiokas, Leonidas and Humphrey, Mary Beth},
  title = {The inhibitor of MyoD Family A (I-MFA) regulates megakaryocyte lineage commitment and terminal differentiation},
  journal = {Blood Cells, Molecules, and Diseases},
  year = {2023},
  volume = {102},
  pages = {102760},
  doi = {10.1016/j.bcmd.2023.102760}
}
Kostenlos starten →